PANOPTICON // METRICS // PAN-MET-011
ALL SYSTEMS NOMINAL ·
METRIC · DOSE COVERAGE

Population Dose Coverage (PDC)

How much of the population is medicated at this moment, across prescription, supplementation, water, and aerosol channels.

Dose CoverageUnit: %Hourly
Metric ID PAN-MET-011 Abbreviation PDC Category Dose Coverage Unit % Frequency Hourly Source PANACEA · VITALNET Classification INTERNAL // QUANTUM-ZONE-TASK-FORCE EYES-ONLY

Formula

Share of the managed population currently receiving a maintenance compound by any channel.

Thresholds & Bands

BandRangeState
Saturated≥ 85ok
Partial60-85warn
Thin< 60crit

Why This Metric Matters

Population Dose Coverage is the foundational metric of the PANOPTICON system — it measures the Directorate's real-time ability to maintain biochemical influence over the managed population. A saturated PDC ensures behavioral stability, suppresses emergent dissent at the neurochemical level, and sustains the pharmacological dependency that underpins revenue continuity. Drops below the saturation threshold correlate directly with spikes in non-compliance, unscheduled healthcare utilization, and public unrest indicators.

Threshold Justification

The 85% saturation floor was derived from PANACEA population-dynamics modeling, which identified that below this level, untreated clusters reach sufficient density to generate self-reinforcing withdrawal cascades. The 60% critical threshold marks the point at which ambient dosing channels alone cannot compensate for prescription lapses, requiring emergency Vector Fleet deployment.

Historical Context

PDC was 54% at program inception, relying solely on prescription channels. The introduction of water-additive programs in 2024 and aerosol Vector deployment in early 2025 drove coverage above 80% for the first time. The metric has remained above the saturation threshold since Q2 2025, with brief dips during municipal infrastructure disruptions.

Collection Method

PDC is computed hourly by PANACEA from a fusion of four data streams: prescription-fill telemetry from partner pharmacies via the Synaptic Data Fabric, VITALNET biometric sensors detecting active compound metabolites, water-treatment facility dosing logs from the Tapline subsystem, and Vector Fleet aerosol-dispersion confirmation receipts. Each channel's contribution is weighted by bioavailability modeling.

Known Failure Modes

VITALNET metabolite detection produces false negatives in subjects with high hepatic clearance rates, underreporting coverage by an estimated 2-4% in certain demographics. Water-channel data lags by up to 6 hours due to municipal reporting cycles, creating brief phantom dips in the hourly feed. Aerosol dispersion confirmation is weather-dependent and may overreport in high-wind conditions where plume modeling diverges from actual ground-level exposure.

Related Metrics

← Back to Metrics